ethyl thieno[2,3-b]pyridine-5-carboxylate

Catalog No.: 
ACIUOV615
CAS No.: 
99429-77-3
Molecular Formula: 
C10H9NO2S
Molecular Weight: 
207.25
ethyl thieno[2,3-b]pyridine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$376.00InquiryInquiry
250mg98%$604.00InquiryInquiry
1g98%$1508.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameethyl thieno[2,3-b]pyridine-5-carboxylate
IUPAC Nameethyl thieno[2,3-b]pyridine-5-carboxylate
MDL No.MFCD28676453
Molecular FormulaC10H9NO2S
Molecular Weight207.25
SMILESO=C(C1=CN=C2C(C=CS2)=C1)OCC
InChI KeyPBSNIODLDCURGJ-UHFFFAOYSA-N
Synonymethyl thieno[2,3-b]pyridine-5-carboxylate;Thieno[2,3-b]pyridine-5-carboxylic acid, ethyl ester
CAS No.99429-77-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIUOV615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMRPC632 route compound structure diagram
    ACMRPC632117390-38-2In Stock
  4. Then
  5. ACIUOV615 route product structure diagram
    ACIUOV61599429-77-3
Inquiry

2. ACIUOV615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACMRPC632 route compound structure diagram
    ACMRPC632117390-38-2In Stock
  4. Then
  5. ACIUOV615 route product structure diagram
    ACIUOV61599429-77-3
Inquiry

3. ACIUOV615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIUOV615 route product structure diagram
    ACIUOV61599429-77-3
Inquiry

Comments (0)